PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text
How Do PARP Inhibitors Work In Cancer? | Dana-Farber Cancer Institute
Focus on suppressive macrophages may boost effects of PARP inhibitors
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
The role of PARP inhibitors and BRCA mutation status in DNA repair and... | Download Scientific Diagram
PARP inhibitor - Wikipedia
PARP inhibitors in cancer treatment | OncologyPRO
PARP Inhibition | PARP Inhibitor Review
Cancers | Free Full-Text | PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
Role of PARP Inhibitors in BRCA-Related Malignancies
The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment
PARP Inhibitors in Ovarian Cancer | IntechOpen
PARP inhibitors stumble in breast cancer | Nature Biotechnology
FDA Approves Olaparib, Rucaparib to Treat Prostate Cancer - National Cancer Institute
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
JCI - The evolving landscape of predictive biomarkers of response to PARP inhibitors
PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review | Semantic Scholar
PARP inhibitors in ovarian cancer - ScienceDirect
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors | Bentham Science
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
